Literature DB >> 1727169

Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease.

L V Laitinen1, A T Bergenheim, M I Hariz.   

Abstract

Between 1985 and 1990, the authors performed stereotactic posteroventral pallidotomies on 38 patients with Parkinson's disease whose main complaint was hypokinesia. Upon re-examination 2 to 71 months after surgery (mean 28 months), complete or almost complete relief of rigidity and hypokinesia was observed in 92% of the patients. Of the 32 patients who before surgery also suffered from tremor, 26 (81%) had complete or almost complete relief of tremor. The L-dopa-induced dyskinesias and muscle pain had greatly improved or disappeared in most patients, and gait and speech volume also showed remarkable improvement. Complications were observed in seven patients: six had a permanent partial homonymous hemianopsia (one also had transient dysphasia and facial weakness) and one developed transitory hemiparesis 1 week after pallidotomy. The results presented here confirm the 1960 findings of Svennilson, et al., that parkinsonian tremor, rigidity, and hypokinesia can be effectively abolished by posteroventral pallidotomy, an approach developed in 1956 and 1957 by Lars Leksell. The positive effect of posteroventral pallidotomy is believed to be based on the interruption of some striopallidal or subthalamopallidal pathways, which results in disinhibition of medial pallidal activity necessary for movement control.

Entities:  

Mesh:

Year:  1992        PMID: 1727169     DOI: 10.3171/jns.1992.76.1.0053

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  117 in total

1.  Acute and chronic effects of anteromedial globus pallidus stimulation in Parkinson's disease.

Authors:  F Durif; J J Lemaire; B Debilly; G Dordain
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

2.  Cognitive functioning after subthalamic nucleotomy for refractory Parkinson's disease.

Authors:  R J McCarter; N H Walton; A F Rowan; S S Gill; M Palomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

3.  Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia Nigra pars reticulata.

Authors:  S R Bradley; M J Marino; M Wittmann; S T Rouse; H Awad; A I Levey; P J Conn
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

Review 4.  Neural transplantation for Parkinson's disease.

Authors:  I Date; T Ohmoto
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

5.  Surgery for movement disorders.

Authors:  Ralph Gregory
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

Review 6.  Applications of electrical pacing in the body.

Authors:  Mervyn Deitel
Journal:  Obes Surg       Date:  2004-09       Impact factor: 4.129

Review 7.  Stereotactic implantation of deep brain stimulation electrodes: a review of technical systems, methods and emerging tools.

Authors:  Simone Hemm; Karin Wårdell
Journal:  Med Biol Eng Comput       Date:  2010-06-02       Impact factor: 2.602

8.  Effect of chronic pallidal deep brain stimulation on off period dystonia and sensory symptoms in advanced Parkinson's disease.

Authors:  T J Loher; J-M Burgunder; S Weber; R Sommerhalder; J K Krauss
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

9.  STN vs. GPi Deep Brain Stimulation: Translating the Rematch into Clinical Practice.

Authors:  Nolan R Williams; Kelly D Foote; Michael S Okun
Journal:  Mov Disord Clin Pract       Date:  2014-04-01

Review 10.  Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?

Authors:  Thomas Wichmann; Mahlon R DeLong
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.